Control of MicroRNA-21 expression in colorectal cancer cells by oncogenic epidermal growth factor/Ras signaling and Ets transcription factors

DNA and Cell Biology

Volumn 31, Issue 8, 2012, Pages 1403-1411

  Kern, Hanna B ^a   Niemeyer, Brian F ^a   Parrish, Janet K ^a   Kerr, Carol A ^a   Yaghi, Nasser K ^a   Prescott, Jason D ^b   Gutierrez Hartmann, Arthur ^a,b   Jedlicka, Paul ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DICER; EPIDERMAL GROWTH FACTOR; MICRORNA 21; MITOGEN ACTIVATED PROTEIN KINASE; RAS PROTEIN; TRANSCRIPTION FACTOR ETS; TRANSFORMING GROWTH FACTOR BETA1;

AMINO TERMINAL SEQUENCE; ARTICLE; CANCER CELL; CARCINOGENESIS; CELL DENSITY; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; MOLECULAR DYNAMICS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN STABILITY; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

CELL LINE, TUMOR; COLORECTAL NEOPLASMS; EPIDERMAL GROWTH FACTOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; ONCOGENE PROTEIN P21(RAS); PROTO-ONCOGENE PROTEINS C-ETS; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 84864607352     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2011.1469     Document Type: Article

References (37)

1. Cai, X., Hagedorn, C.H., and Cullen, B.R. (2004). Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. Rna 10, 1957-1966.
2. Cowden Dahl, K.D., Dahl, R., Kruichak, J.N., and Hudson, L.G. (2009). The epidermal growth factor receptor responsive miR- 125a represses mesenchymal morphology in ovarian cancer cells. Neoplasia 11, 1208-1215.
3. Cowden Dahl, K.D., Zeineldin, R., and Hudson, L.G. (2007). PEA3 is necessary for optimal epidermal growth factor receptor-stimulated matrix metalloproteinase expression and invasion of ovarian tumor cells. Mol Cancer Res 5, 413-421.
4. Crawford, H.C., Fingleton, B., Gustavson, M.D., Kurpios, N., Wagenaar, R.A., Hassell, J.A., and Matrisian, L.M. (2001). The PEA3 subfamily of Ets transcription factors synergizes with beta-catenin-LEF-1 to activate matrilysin transcription in intestinal tumors. Mol Cell Biol 21, 1370-1383.
5. Davis, B.N., and Hata, A. (2009). Regulation of MicroRNA Biogenesis: A miRiad of mechanisms. Cell Commun Signal 7, 18.
6. Davis, B.N., Hilyard, A.C., Lagna, G., and Hata, A. (2008). SMAD proteins control DROSHA-mediated microRNA maturation. Nature 454, 56-61.
7. Eckel, K.L., Tentler, J.J., Cappetta, G.J., Diamond, S.E., and Gutierrez-Hartmann, A. (2003). The epithelial-specific ETS transcription factor ESX/ESE-1/Elf-3 modulates breast cancerassociated gene expression. DNA Cell Biol 22, 79-94.
8. Frezzetti, D., De Menna, M., Zoppoli, P., Guerra, C., Ferraro, A., Bello, A.M., De Luca, P., Calabrese, C., Fusco, A., Ceccarelli, M., et al. (2011) Upregulation of miR-21 by Ras in vivo and its role in tumor growth. Oncogene 30, 275-286.
9. Fujita, S., Ito, T., Mizutani, T., Minoguchi, S., Yamamichi, N., Sakurai, K., and Iba, H. (2008). miR-21 Gene expression triggered by AP-1 is sustained through a double-negative feedback mechanism. J Mol Biol 378, 492-504.
10. Fukao, T., Fukuda, Y., Kiga, K., Sharif, J., Hino, K., Enomoto, Y., Kawamura, A., Nakamura, K., Takeuchi, T., and Tanabe, M. (2007). An evolutionarily conserved mechanism for micro- RNA-223 expression revealed by microRNA gene profiling. Cell 129, 617-631.
11. Ghildiyal, M., and Zamore, P.D. (2009). Small silencing RNAs: An expanding universe. Nat Rev Genet 10, 94-108.
12. Green, S., Issemann, I., and Sheer, E. (1988). A versatile in vivo and in vitro eukaryotic expression vector for protein engineering. Nucleic Acids Res 16, 369.
13. Hwang, H.W., Wentzel, E.A., and Mendell, J.T. (2009). Cell-cell contact globally activates microRNA biogenesis. Proc Natl Acad Sci U S A 106, 7016-7021.
14. Ijichi, H., Ikenoue, T., Kato, N., Mitsuno, Y., Togo, G., Kato, J., Kanai, F., Shiratori,Y., andOmata,M. (2001). Systematic analysis of the TGF-beta-Smad signaling pathway in gastrointestinal cancer cells. Biochem Biophys Res Commun 289, 350-357.
15. Jedlicka, P., and Gutierrez-Hartmann, A. (2008). Ets transcription factors in intestinal morphogenesis, homeostasis and disease. Histol Histopathol 23, 1417-1424.
16. Jedlicka, P., Sui, X., and Gutierrez-Hartmann, A. (2009). The Ets dominant repressor En/Erm enhances intestinal epithelial tumorigenesis in ApcMin mice. BMC Cancer 9, 97.
17. Jedlicka, P., Sui, X., Sussel, L., and Gutierrez-Hartmann, A. (2009). Ets transcription factors control epithelial maturation and transit and crypt-villus morphogenesis in the mammalian intestine. Am J Pathol 174, 1280-1290.
18. Kim, V.N., Han, J., and Siomi, M.C. (2009). Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol 10, 126-139.
19. Klase,Z., Kale,P.,Winograd,R., Gupta,M.V.,Heydarian,M., Berro, R.,McCaffrey, T., andKashanchi, F. (2007).HIV-1 TARelement is processed by Dicer to yield a viral micro-RNA involved in chromatin remodeling of the viral LTR. BMC Mol Biol 8, 63.
20. Kota, J., Chivukula, R.R., O'Donnell, K.A., Wentzel, E.A., Montgomery, C.L., Hwang, H.W., Chang, T.C., Vivekanandan, P., Torbenson, M., Clark, K.R., et al. (2009). Therapeutic micro- RNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 137, 1005-1017.
21. Krichevsky, A.M., and Gabriely, G. (2009). miR-21: A small multi-faceted RNA. J Cell Mol Med 13, 39-53.
22. Loffler, D., Brocke-Heidrich, K., Pfeifer, G., Stocsits, C., Hackermuller, J., Kretzschmar, A.K., Burger, R., Gramatzki, M., Blumert, C., Bauer, K., et al. (2007). Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3- mediated induction of microRNA-21 through a highly conserved enhancer. Blood 110, 1330-1333.
23. McKinsey, E.L., Parrish, J.K., Irwin, A.E., Niemeyer, B.F., Kern, H.B., Birks, D.K., and Jedlicka, P. (2011). A novel oncogenic mechanism in Ewing sarcoma involving IGF pathway targeting by EWS/Fli1-regulated microRNAs. Oncogene 30, 4910-4920.
24. Paroo, Z., Ye, X., Chen, S., and Liu, Q. (2009). Phosphorylation of the human microRNA-generating complex mediates MAPK/ Erk signaling. Cell 139, 112-122.
25. Schetter, A.J., Leung, S.Y., Sohn, J.J., Zanetti, K.A., Bowman, E.D., Yanaihara, N., Yuen, S.T., Chan, T.L., Kwong, D.L., Au, G.K., et al. (2008). MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. Jama 299, 425-436.
26. Seike, M., Goto, A., Okano, T., Bowman, E.D., Schetter, A.J., Horikawa, I., Mathe, E.A., Jen, J., Yang, P., Sugimura, H., et al. (2009). MiR-21 is an EGFR-regulated anti- apoptotic factor in lung cancer in never-smokers. Proc Natl Acad Sci U S A 106, 12085-12090.
27. Selcuklu, S.D., Donoghue, M.T., and Spillane, C. (2009). miR-21 as a key regulator of oncogenic processes. Biochem Soc Trans 37, 918-925.
28. Sotiropoulou, G., Pampalakis, G., Lianidou, E., and Mourelatos, Z. (2009). Emerging roles of microRNAs as molecular switches in the integrated circuit of the cancer cell. Rna 15, 1443-1461
29. Talotta, F., Cimmino, A., Matarazzo, M.R., Casalino, L., De Vita, G., D'Esposito, M., Di Lauro, R., and Verde, P. (2009). An autoregulatory loop mediated by miR-21 and PDCD4 controls the AP-1 activity in RAS transformation. Oncogene 28, 73-84.
30. Trang, P., Medina, P.P., Wiggins, J.F., Ruffino, L., Kelnar, K., Omotola, M., Homer, R., Brown, D., Bader, A.G., Weidhaas, J.B., and Slack, F.J. (2010) Regression of murine lung tumors by the let-7 microRNA. Oncogene 29, 1580-1587.
31. Trang, P., Weidhaas, J.B., and Slack, F.J. (2008). MicroRNAs as potential cancer therapeutics. Oncogene 27 Suppl 2, S52-S57.
32. Visone, R., and Croce, C.M. (2009). MiRNAs and cancer. Am J Pathol 174, 1131-1138.
33. Wang, V., and Wu, W. (2009). MicroRNA-based therapeutics for cancer. BioDrugs 23, 15-23.
34. Wasylyk, B., Hagman, J., and Gutierrez-Hartmann, A. (1998a). Ets transcription factors: nuclear effectors of the Ras-MAPkinase signaling pathway. Trends Biochem Sci 23, 213-216.
35. Wasylyk, B., Hagman, J., and Gutierrez-Hartmann, A. (1998b). Ets transcription factors: nuclear effectors of the Ras-MAPkinase signaling pathway. Trends Biochem Sci 23, 213-216.
36. Weidhaas, J.B., Babar, I., Nallur, S.M., Trang, P., Roush, S., Boehm, M., Gillespie, E., and Slack, F.J. (2007). MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy. Cancer Res 67, 11111-11116.
37. Winter, J., Jung, S., Keller, S., Gregory, R.I., and Diederichs, S. (2009). Many roads to maturity: MicroRNA biogenesis pathways and their regulation. Nat Cell Biol 11, 228-234.